Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Takuya Suga is active.

Publication


Featured researches published by Takuya Suga.


The Journal of Antibiotics | 2012

Aranorosin circumvents arbekacin-resistance in MRSA by inhibiting the bifunctional enzyme AAC(6')/APH(2″).

Takuya Suga; Takahiro Ishii; Masato Iwatsuki; Tsuyoshi Yamamoto; Kenichi Nonaka; Rokuro Masuma; Hidehito Matsui; Hideaki Hanaki; Satoshi Omacr; mura; Kazuro Shiomi

Aranorosin circumvents arbekacin-resistance in MRSA by inhibiting the bifunctional enzyme AAC(6′)/APH(2″)


Bioorganic & Medicinal Chemistry Letters | 2013

Cytosporone S with antimicrobial activity, isolated from the fungus Trichoderma sp. FKI-6626

Takahiro Ishii; Kenichi Nonaka; Takuya Suga; Rokuro Masuma; Satoshi Ōmura; Kazuro Shiomi

A new microbial metabolite, cytosporone S (1) was isolated from a fermentation broth of the fungus Trichoderma sp. FKI-6626. Its chemical structure was determined primarily by NMR spectroscopy and mass spectrometry. Compound 1 showed antimicrobial activity against several Gram-positive and Gram-negative bacteria and fungi.


The Journal of Antibiotics | 2015

Coculnol, a new penicillic acid produced by a coculture of Fusarium solani FKI-6853 and Talaromyces sp. FKA-65

Kenichi Nonaka; Takuya Chiba; Takuya Suga; Yukihiro Asami; Masato Iwatsuki; Rokuro Masuma; Satoshi Ōmura; Kazuro Shiomi

Coculnol, a new penicillic acid produced by a coculture of Fusarium solani FKI-6853 and Talaromyces sp. FKA-65


Bioorganic & Medicinal Chemistry Letters | 2009

Identification of 2-aminobenzimidazoles as potent melanin-concentrating hormone 1-receptor (MCH1R) antagonists.

Minoru Moriya; Hiroyuki Kishino; Shunji Sakuraba; Toshihiro Sakamoto; Takuya Suga; Hidekazu Takahashi; Takao Suzuki; Masahiko Ito; Junko Ito; Ryuichi Moriya; Norihiro Takenaga; Hisashi Iwaasa; Akane Ishihara; Akio Kanatani; Takehiro Fukami

A series of 2-aminobenzimidazole-based MCH1R antagonists was identified by core replacement of the aminoquinoline lead 1. Subsequent modification of the 2- and 5-positions led to improvement in potency and intrinsic clearance. Compound 25 exhibited good plasma and brain exposure, and attenuated MCH induced food intake at 30mg/kg PO in rats.


The Journal of Antibiotics | 2015

Ascosteroside C, a new mitochondrial respiration inhibitor discovered by pesticidal screening using recombinant Saccharomyces cerevisiae

Takuya Suga; Yukihiro Asami; Shohei Hashimoto; Kenichi Nonaka; Masato Iwatsuki; Takuji Nakashima; Ryohei Sugahara; Takahiro Shiotsuki; Takenori Yamamoto; Yasuo Shinohara; Naoya Ichimaru; Masatoshi Murai; Hideto Miyoshi; Satoshi Ōmura; Kazuro Shiomi

Ascosteroside C, a new mitochondrial respiration inhibitor discovered by pesticidal screening using recombinant Saccharomyces cerevisiae


The Journal of Antibiotics | 2016

Paraphaeosphaeride D and berkleasmin F, new circumventors of arbekacin resistance in MRSA, produced by Paraphaeosphaeria sp. TR-022

Takuya Suga; Mayu Shiina; Yukihiro Asami; Masato Iwatsuki; Tsuyoshi Yamamoto; Kenichi Nonaka; Rokuro Masuma; Hidehito Matsui; Hideaki Hanaki; Susumu Iwamoto; Hideyuki Onodera; Kazuro Shiomi; Satoshi Ōmura

Two new compounds, designated paraphaeosphaeride D (1) and berkleasmin F (2) together with a previously known compound, berkleasmin A (3), isolated from a culture broth of the fungus Paraphaeosphaeria sp. TR-022, proved to be new circumventors of arbekacin (ABK) resistance in methicillin-resistant Staphylococcus aureus (MRSA). The structures of 1 and 2 were elucidated by spectroscopic analyses, including various NMR experiments. All compounds showed 10–100 times ABK circumvention activities using the paper disc method and reduced the MIC values of ABK against MRSA from 16 μg ml−1 to 4 μg ml−1 (fourfold) using the agar dilution method. These new compounds might be promising lead compounds for developing circumventors of ABK resistance in MRSA.


Journal of General and Applied Microbiology | 2015

Trichopolyn VI: a new peptaibol insecticidal compound discovered using a recombinant Saccharomyces cerevisiae screening system

Takuya Suga; Yukihiro Asami; Shohei Hashimoto; Kenichi Nonaka; Masato Iwatsuki; Takuji Nakashima; Yoshihiro Watanabe; Ryohei Sugahara; Takahiro Shiotsuki; Takenori Yamamoto; Yasuo Shinohara; Naoya Ichimaru; Masatoshi Murai; Hideto Miyoshi; Satoshi Ōmura; Kazuro Shiomi

In the course of searching for insecticides from soil microorganisms, we found that a fermentation broth of the fungus, Trichoderma brevicompactum FKI-6324, produced Trichopolyn VI, a new peptaibol, which possessed significant insecticidal potential. Spectroscopic analysis showed the compound to be a new trichopolyn I derivative. This paper describes the isolation, structure elucidation and biological activity of trichopolyn VI.


The Journal of Antibiotics | 2018

Hamuramicins A and B, 22-membered macrolides, produced by an endophytic actinomycete Allostreptomyces sp. K12-0794

Takuya Suga; Tōru Kimura; Yuki Inahashi; Masato Iwatsuki; Kenichi Nonaka; Akira Také; Atsuko Matsumoto; Yōko Takahashi; Satoshi Ōmura; Takuji Nakashima

Two new compounds, designated as hamuramicins A (1) and B (2), were isolated from the cultured broth of an endophytic actinomycete Allostreptomyces sp. K12-0794 by silica gel column chromatography and HPLC. The structures of 1 and 2 were elucidated as 22-membered macrolide containing triene and trienone with an alkyl side chain by spectroscopic analyses including NMR experiments. Both compounds showed growth inhibition activity against Kocuria rhizophia and Xanthomonas oryzae pv. oryzae as well as human cell line toxicity.


The Journal of Antibiotics | 2018

Pyrizomicin A and B: structure and bioactivity of new thiazolyl pyridines from Lechevalieria aerocolonigenes K10-0216

Tōru Kimura; Yuki Inahashi; Hirotaka Matsuo; Takuya Suga; Masato Iwatsuki; Kazuro Shiomi; Yōko Takahashi; Satoshi Ōmura; Takuji Nakashima

Two new antibiotics, designated pyrizomicin A and B, were isolated from the cultured broth of a rare actinomycete strain, Lechevalieria aerocolonigenes K10-0216, by silica gel and HPLC purification. The chemical structures of pyrizomicin A and B were elucidated as new thiazolyl pyridine compounds by nuclear magnetic resonance and mass spectrometry. Pyrizomicin A and B both showed antimicrobial activity.


Journal of Natural Products | 2018

Pestynol, an Antifungal Compound Discovered Using a Saccharomyces cerevisiae 12geneΔ0HSR-iERG6-Based Assay

Katsuyuki Sakai; Tomoyasu Hirose; Masato Iwatsuki; Takumi Chinen; Toru Kimura; Takuya Suga; Kenichi Nonaka; Takuji Nakashima; Toshiaki Sunazuka; Takeo Usui; Yukihiro Asami; Satoshi O̅mura; Kazuro Shiomi

The multidrug-sensitive budding yeast, Saccharomyces cerevisiae 12geneΔ0HSR-iERG6, is very useful in antifungal screens. A novel compound, named pestynol (1), was discovered from a culture of the fungus Pestalotiopsis humus FKI-7473 using the multidrug-sensitive yeast. The structure of 1 was elucidated by NMR studies and modified Moshers method as (1 R,2 R,3 R,4 R)-( E)-5-(7,11-dimethyl-3-methylenedodeca-6,10-dien-1-yn-1-yl)cyclohex-5-ene-1,2,3,4-tetraol. Compound 1 showed antimicrobial activity against the Gram-positive bacteria, Klebsiella pneumoniae, and S. cerevisiae 12geneΔ0HSR-iERG6 and Mucor racemosus, but displayed only weak cytotoxicity against various human cancer cell lines. Compound 1 displayed antifungal activities against S. cerevisiae 12geneΔ0HSR-iERG6 and Mucor racemosus at 10 μg/disc.

Collaboration


Dive into the Takuya Suga's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Norikazu Ohtake

Taisho Pharmaceutical Co.

View shared research outputs
Researchain Logo
Decentralizing Knowledge